LUNG

Pulmonx Corporation (LUNG) is a pioneering medical technology firm headquartered in Redwood City, California, focused on revolutionizing the treatment of chronic obstructive pulmonary disease (COPD) with its minimally invasive solutions. The company is renowned for the Zephyr® Endobronchial Valve, an advanced therapeutic product that enhances lung function and elevates patient quality of life while reducing procedural risks. With a strong commitment to improving clinical outcomes, Pulmonx is strategically positioned as a leader in the dynamic respiratory disease treatment sector, targeting a significant and expanding patient demographic.